CROI 2017 Abstract e-Book

Abstract eBook

Keyword Index

Household contacts 885 Housing 1013 HPgV-2 583 HPTN 052 1002 HPV 591, 592, 593, 594, 595, 597 HSIL 591, 595

Infection 773 Infection staging 511 Infectivity 169 Inflammasome 167, 222, 733 Inflammation 126, 133, 212, 213, 256, 280, 342, 608, 648, 786, 803, 949 · Markers 212, 325, 526, 661, 667, 674, 675, 824 Inflammatory cytokine/chemokine 226, 593 Influenza vaccine 258 Ingenol 123 Injectable 421LB Injection drug use 559, 578, 869, 875 Inmate 957 Innate immunity 167, 168, 211, 233, 259, 312 Insulin resistance 525, 691 Insulin sensitivity 692 Insurance 455, 663, 972, 1012 Integrase 16, 17, 155, 497, 499 Integrase inhibitor (INI) 16, 434, 442, 448, 465, 497, 731, 732, 812 · Resistance 460, 500LB Integrase mutation 16, 157, 478, 493 Integrase strand transfer inhibitor 40, 372, 478, 493, 496, 497, 498 Integrated DNA 68, 285, 300 Integration 637 Integration site analysis 301, 304 Integrin 64LB Interleukin 6 471 Interleukin-7 226 Intermittency TB treatment 719 Internet 892, 898 Intervention 892, 965, 968, 1014 Intestine 314 Intimate partner violence 894, 927 Intracellular pharmacology 404, 405, 408 Intravenous immunoglobulin 324 ION-4 138 Iron 721 Iron homeostasis 377 Isoniazid 409a, 79 Isoniazid preventative therapy 78, 706, 708, 709, 710, 720 Jamaica 923 Kaposi sarcoma 605, 818 Kenya 22, 36, 116, 488, 832, 847, 856, 1025, 1037 Kidney 688 · Function 649 · Transplantation 688 KIR3DS1 274 Knowledge 834 Kulldorff spatial-scan statistics 847 Lag3 337 Lake Victoria 861 Large loop excision of the transformation zone (LLETZ) 941 Late presentation 441, 1019 Latency 121, 196, 283, 297, 308, 311, 315, 327, 338LB · Models 306, 311 · Reversing agents 123, 283, 305, 309, 310, 311, 338LB Latent HIV 304 · HIV-1 reactivation 121, 122, 283, 307, 316, 338LB · HIV-1 reservoir 165, 281, 292, 293, 296, 305, 306, 317, Intensification 68, 382 Interaction 392, 404, 411 Interferon 181LB · Alpha 233 · Gamma 375 · -free 570 Lamivudine 428, 458 Langerhans cell 262

318, 326 · Reservoir 300, 310, 333, 338LB

Latent tuberculosis 711 Latin America 719 LDV/SOF 404 Ledipasvir 138, 568LB, 573

Human hepatic stellate cell line 585 Human immunodeficiency virus 335 Human papillomavirus 805 Human papillomavirus vaccine 597, 805 Human pegivirus 583

Leishmaniasis 752 Lentivirus 175, 269 Levonorgestrel 423, 944 Life expectancy 929 Linkage 518 Linkage to care and treatment 110, 479, 547, 729, 839, 911, 997, 1009, 110, 1018, 1019 Lipid profile 575 Lipids 232, 612 Lipohypertrophy 696, 703 Live imaging 14 Liver · Biopsies 525, 531 · Cirrhosis 535, 538, 551

Humanized mice 219, 254 Humoral immunity 787 Hyper acute 291 Hypercholesterolemia 130 Hypertension 130, 637, 638, 642 Ibalizumab 438, 449LB IDU 578, 878 IFN 19, 60, 227 IFN-a 176, 220 IFN-alfa 118, 176, 253, 326, 327 IFN-g 265LB IL-1 126 IL-17A 204 IL-18 223 IL-37 167 IL-6 170, 673 IL28B 571 Imaging 126, 155 Immigrant 851, 1016, 1017 Immune

· Disease 260LB, 530, 588, 703 · Disease progression 525, 527 · Endpoint 533 · Fibrosis 585, 698, 703, 704 · Histology 531 · Transplantation 540, 541 Long non-coding RNA 162 Long-acting 38, 437, 438, 439, 449LB Long-term follow-up 464, 1021 Long-term nonprogressor 245 Longitudinal 31, 933 Longitudinal study 251, 351, 352LB, 539 Lopinavir 378 Lopinavir/ritonavir 778, 781, 819 Low-income countries 714 Low-level viremia 113, 932 LRA 308 LTFU 990 LTR 194 Lumbar spine 678 Lung 232, 661 · Cancer 131, 606 Lymph node 65, 221, 251, 266, 288, 407 Lymphoid tissue 63, 267 Lymphoma 603 M184V 503 mAb 415, 760 Macaque models 209, 321, 322 Macrophage 174, 259, 260LB Macrophage tropism 365 Macrophages 232 Magnetic resonance imaging 387, 402 Magnetic resonance spectroscopy 394, 398 Loss of detectability 794 Loss to follow-up 1000 Low birth weight 777 Low bone mineral density 683

· Activation 60, 87, 118, 159, 206, 207, 222, 230, 252, 253, 254, 258, 280, 281, 339, 344, 605, 618, 627, 628, 641, 648,

674, 675, 786, 800, 801, 802 · Checkpoint 234, 337, 385 · Exhaustion 321, 337, 641, 674, 800 · Reconstitution 222 · Reconstitution inflammatory syndrome (IRIS) 238, 287, 731, 732, 733, 81LB · Recovery 213, 225, 467, 470, 676 · Response 176, 220 · Restoration 226, 799 · Senescence 641 Immunologic failure 222, 276 Immunologic response 176, 206, 226, 229, 248 Immunology 167, 203, 747 Immunomodulation 802 Immunosenescence 605 Immunosuppression 117, 203, 688, 710 Immunotherapy 326, 335 Impact evaluation 968, 1040 Implant 420, 422LB Implementation 707, 972 Implementation science 110, 556, 706, 743, 965, 968, 970, 1004, 1005 In vitro 499 In vivo 220 Incarceration 1044 Incentives 33 Incidence 137LB, 30, 34LB, 35, 514, 603, 764, 792, 863, 865, 899 Incidence assay 514, 878, 879, 880, 888, 889 Incidence rates 114LB, 467, 601, 880 Incident infection 765 India 456, 559, 883 Indoleamine 2,3-dioxygenase (IDO) 252

Keyword Index

Magnetoencephalography 403 Maintenance therapy 451LB, 458

MAIT cell 239, 587 MAIT cells 275, 276 Malawi 602, 850, 895, 896 Male circumcision 34LB, 87, 984 Male services 998 Malignancies 470, 597, 601 Malnutrition 117 Mapping 850 Maraviroc 417, 585, 981 Marginalized populations 853 Mathematical model 112, 165, 456, 1031, 1034, 1048 Mathematical Modelling 1027, 1033, 1036, 1039, 1040, 1041,

Inducible HIV-1 281, 795 Inducible reservoir 285 Inequity 968 Infant 1056LB, 27, 760, 774, 792, 796, 803, 935 Infants 783

CROI 2017 488